Literature DB >> 1555895

Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor beta 1.

S Chakrabarty1.   

Abstract

The regulatory effect of transforming growth factor beta 1 (TGF-beta 1) on the adhesion of human colon-carcinoma cells to the extracellular matrix (ECM) was investigated. ECMs used in this study included tissue-culture wells coated with fibronectin, laminin, collagen and BSA, as well as plastic wells. Three phenotypically different human colon-carcinoma cell lines (Moser, HCT116, and KM12SM) were used. The Moser cell line is moderately differentiated and, in terms of the diversity of responses elicited by TGF-beta 1, is the human colon-carcinoma cell line most responsive to TGF-beta 1 as reported to date. By comparison, the undifferentiated HCT116 and the highly metastatic KM12SM cells are unresponsive to this growth factor. We showed that TGF-beta 1 regulated the adhesion responses of all 3 cell lines. However, the response profiles as well as the endogenous adhesive properties of each cell line were quite different from those of the others. Endogenous Arg-Gly-Asp(RGD)-related receptors were present on the HCT116 but not on the other cells. The observed regulatory effect of TGF-beta 1 was contingent on the cell line, the type of ECM, and the growth-factor treatment protocol used. When cells were treated with TGF-beta 1 for 16 hr prior to exposure to ECM in a 4-hr adhesion assay, a significant increase in adhesion to fibronectin and collagen was observed for the Moser cells. For the identical experimental protocol, the KM12SM cells responded by increasing adhesion to fibronectin, while the HCT116 cells responded by decreasing adhesion to collagen. Kinetic analyses of TGF-beta 1 treatment showed that increased adhesion response to laminin was induced in the Moser cells after 2 hr of growth-factor treatment. This response declined rapidly upon further exposure of the cells to TGF-beta 1. Simultaneous exposure of cells to both TGF-beta 1 and ECM negated the adhesion responses described above. The up-modulation of adhesion to fibronectin, laminin and collagen by TGF-beta 1 was mediated through RGD-related integrin receptors. RGD-containing peptides effectively blocked the enhanced adhesion responses induced by TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555895     DOI: 10.1002/ijc.2910500624

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  A fluorescence based cell adhesion assay using Terasaki plates.

Authors:  M R Novelli; W F Bodmer; H Durbin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-02       Impact factor: 2.416

2.  Cancer stem cells from colorectal cancer-derived cell lines.

Authors:  Trevor M Yeung; Shaan C Gandhi; Jennifer L Wilding; Ruth Muschel; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

3.  Transforming growth factor beta suppresses beta-catenin/Wnt signaling and stimulates an adhesion response in human colon carcinoma cells in a Smad4/DPC4 independent manner.

Authors:  Huijun Wang; Shanthi Rajan; Guangming Liu; Subhas Chakrabarty
Journal:  Cancer Lett       Date:  2008-03-25       Impact factor: 8.679

Review 4.  Growth factor regulation of integrin-mediated cell motility.

Authors:  K Matsumoto; B L Ziober; C C Yao; R H Kramer
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

5.  Switch of transforming growth factor beta function from tumor suppression to stimulation in adenomatous polyposis coli (APC) knocked-down human colon carcinoma cells.

Authors:  Hongmei Wang; Moltira Promkan; Guangming Liu; Subhas Chakrabarty
Journal:  Cancer Lett       Date:  2008-09-06       Impact factor: 8.679

6.  TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell.

Authors:  Guoqiong Lei; Sushun Liu; Xin Yang; Chao He
Journal:  Can J Gastroenterol Hepatol       Date:  2021-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.